Rasagiline Mesylate Tablet
Product Images NDC 71921-407

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline Mesylate (NDC 71921-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rasagiline-container-1 (Rasagiline Container 1)

This is information about Rasagiline tablets. Each tablet contains Rasagiline mesylate equivalent to 0.5 mg rasagiline. The package contains 30 tablets and is labeled for prescription use only. The package is child-resistant and should be stored at controlled room temperature between 59°F to 86°F. The manufacturer is Indoco Remedies Ltd. located in Goa, India. The tablets are manufactured for Florida Pharmaceutical Products, LLC in Boca Raton, FL. For further information, refer to the prescribing information accompanying the product.*

FDA Label Image

Rasagiline-container-2 (Rasagiline Container 2)

This is a description of Rasagiline Tablets, each containing Rasagiline mesylate equivalent to 1 mg Rasagiline. The packaging includes 30 tablets with child-resistant features. The recommended storage temperature is 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Manufactured by Indoco Remedies Ltd. in Goa, India, for Florida Pharmaceutical Products, LLC in Boca Raton, FL. For dosing information, refer to the accompanying prescribing information. Contact toll-free number 1-833-856-0880 for more details.*

FDA Label Image

Str (Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.